Clinical Trial Detail

NCT ID NCT02525757
Title MPDL3280A With Chemoradiation for Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Carboplatin + Paclitaxel

Age Groups: adult

No variant requirements are available.